Home » Topics » Regulatory

Regulatory
RSS

FDA approves Epidiolex for seizures associated with LGS and Dravet syndrome

June 26, 2018

FDA approves moxidectin to treat river blindness

June 14, 2018

Ganovo approved in China for hepatitis C

June 13, 2018

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

FDA approves pegfilgrastim biosimilar Fulphila

June 5, 2018

FDA approves Consensi for osteoarthritis pain and hypertension

June 4, 2018

FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause

May 30, 2018

European Commission grants authorization to Rubraca for recurrent ovarian cancer

May 30, 2018

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

FDA approves Palynziq for adults with phenylketonuria

May 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...